Skip to main content

Afya Limited (AFYA) Stock Forecast

Data as of Nov 1, 2026

Consumer Defensive · Current price $9.74 (-4.18%)

Consensus Target
$17.00
Upside
+74.5%
Analysts
2
Rating
Buy(2.50)

Price Target Range

Low $17.00High $17.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Jan 16, 2026Andre SallesUBS$16.00+64.2%
Sep 8, 2025Andre SallesUBS$19.00+95.0%
Jun 21, 2024Mauricio CepedaMorgan Stanley$19.00+95.0%

AFYA vs Sector & Market

MetricAFYAConsumer Defensive AvgLarge Cap Avg
Analyst Rating2.502.562.41
Analyst Count2919
Target Upside+74.5%+12343.7%+21.5%
P/E Ratio1.1811.2738.49

Revenue Estimates

PeriodLowAvgHigh#
2026-12-31$1.03B$1.03B$1.03B1
2027-03-31$1.13B$1.14B$1.14B1
2027-06-30$1.12B$1.13B$1.13B1
2027-09-30$1.15B$1.15B$1.15B1
2027-12-31$1.13B$1.13B$1.14B1
2028-12-31$4.39B$4.49B$4.59B1

EPS Estimates

PeriodLowAvgHigh#
2026-12-31$2.12$2.13$2.141
2027-03-31$3.53$3.54$3.561
2027-06-30$2.65$2.66$2.681
2027-09-30$2.66$2.67$2.691
2027-12-31$2.65$2.66$2.671
2028-12-31$0.00$0.00$0.001

Frequently Asked Questions

What is the analyst consensus for AFYA?

The consensus among 2 analysts covering Afya Limited (AFYA) is Buy with an average price target of $17.00.

What is the highest price target for AFYA?

The highest price target for AFYA is $19.00, set by Andre Salles at UBS on 2025-09-08.

What is the lowest price target for AFYA?

The lowest price target for AFYA is $16.00, set by Andre Salles at UBS on 2026-01-16.

How many analysts cover AFYA?

2 analysts have issued ratings for Afya Limited in the past 12 months.

Is AFYA a buy or sell right now?

Based on 2 analyst ratings, AFYA has a consensus rating of Buy (2.50/5) with a +74.5% upside to the consensus target of $17.00.

What are the earnings estimates for AFYA?

Analysts estimate AFYA will report EPS of $2.13 for the period ending 2026-12-31, with revenue estimated at $1.03B.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.